Results 21 to 30 of about 7,466 (212)
Farnesol, the farnesol pathway, and the immune-gut-brain axis. [PDF]
Experimental models and clinical evidence suggest that the gut and the central nervous system (CNS) interact in a multifactorial, bidirectional manner. A third player, the immune system, has recently been identified in these interactions, with research linking the gut microbiome to inflammatory conditions, including those affecting
Gates M +5 more
europepmc +2 more sources
Farnesol repurposing for prevention and treatment of Acinetobacter baumannii biofilms
Acinetobacter baumannii has emerged as a multidrug-resistant (MDR) superbug by causing severe infections, with high mortality rates. The ability of A. baumannii to form biofilms significantly contributes to its persistence in diverse environmental and ...
Li Tan +3 more
doaj +2 more sources
Fungal-Bacterial Interactions in Polymicrobial Infections: Hidden Threats. [PDF]
ABSTRACT Polymicrobial infections involving fungi and bacteria represent a major and increasingly recognized clinical challenge, in which interkingdom interactions significantly amplify disease severity, antimicrobial resistance, and treatment failure. Rather than passive co‐existence, fungal–bacterial communities form highly coordinated systems driven
Gourabi MJR +3 more
europepmc +2 more sources
Farnesol: An approach on biofilms and nanotechnology
Abstract Biofilms are important virulence factor in infections caused by microorganisms because of its complex structure, which provide resistance to conventional antimicrobials. Strategies involving the use of molecules capable of inhibiting their formation and also act synergistically with ...
Adelaide Fernandes Costa +2 more
openaire +2 more sources
Farnesol-derived Dicarboxylic Acids in the Urine of Animals Treated with Zaragozic Acid A or with Farnesol [PDF]
Farnesyl diphosphate, the substrate for squalene synthase, accumulates in the presence of zaragozic acid A, a squalene synthase inhibitor. A possible metabolic fate for farnesyl diphosphate is its conversion to farnesol, then to farnesoic acid, and finally to farnesol-derived dicarboxylic acids (FDDCAs) which would then be excreted in the urine.
R G, Bostedor +7 more
openaire +2 more sources
Enhancement of the antifungal activity of some antimycotics by farnesol and reduction of Candida albicans pathogenicity in a quail model experiment [PDF]
Background and Aim: Clinical strains of microorganisms, including pathogenic yeast-like fungi (YLF), are resistant to currently used antifungal agents. Thus, it is relevant to study the combinations of existing antimicrobial drugs and a medicinal extract
Nadezhda Sachivkina +8 more
doaj +1 more source
Background The quorum-sensing molecule farnesol, in opportunistic yeast Candida albicans, modulates its dimorphic switch between yeast and hyphal forms, and biofilm formation. Although there is an increasing interest in farnesol as a potential antifungal
Sima Mohammadi +4 more
doaj +1 more source
Systematic analysis of protein expression in Candida albicans exposed to farnesol
. Background:. The phenotypic switching of Candida spp. plays an important role in the development of vulvovaginal candidiasis (VVC). Farnesol, as a quorum-sensing molecule in Candida albicans, has the ability to prevent yeast-to-hyphal conversion in ...
Feng-Juan Wang, Zhao-Hui Liu, Peng Lyu
doaj +1 more source
Charcot-Marie-Tooth disease (CMT) is a genetically heterogeneous disease affecting the peripheral nervous system that is caused by either the demyelination of Schwann cells or degeneration of the peripheral axon. Currently, there are no treatment options
Na-Young Park +7 more
doaj +1 more source
Functional Characterization of the Small Heat Shock Protein Hsp12p from Candida albicans [PDF]
Hsp12p is considered to be a small heat shock protein and conserved among fungal species. To investigate the expression of this heat shock protein in the fungal pathogen Candida albicans we developed an anti-CaHsp12p antibody.
Mühlschlegel, Fritz A. +16 more
core +1 more source

